Open Access
Access granted
Subscription or Fee Access
Vol 26, No 1 (2015)
- Year: 2015
- Articles: 24
- URL: https://journals.eco-vector.com/0236-3054/issue/view/5944
Articles
INTELLECTUAL IMPAIRMENTS AND SLEEP DISORDERS IN CHILDREN
Abstract
The paper considers an association between sleep disorders and intellectual impairments in children. It gives data on the characteristic types of sleep disorders, such as bedtime resistance; frequent nocturnal awakenings; parasomnias; altered sleep patterns; first of all, a lower proportion of REM sleep. Attention is drawn to the direct relationship between the neurophysiology of sleep and intellectual development in a child, sleep disorders and the pathogenesis of intellectual impairments. The role of the abnormal production of neuromediators in the genesis of sleep disorders in children with intellectual disorders is discussed. Possible approaches to nonpharmacological and pharmacological correction are outlined.
Vrach. 2015;26(1):2-5
2-5
PROBLEM-FREE MATERNITY IN WOMEN WITH TUBERCULOSIS: MYTH OR REALITY?
Abstract
The paper analyzes the specific features of pregnancy, labor, delivery, and early postpartum in 59 women with active tuberculosis versus those in 143 women with clinically cured tuberculosis and in 143 healthy pregnant women. The women with active tuberculosis were noted to have complications in all pregnancy trimesters, during labor and delivery and early postpartum period.
Vrach. 2015;26(1):5-8
5-8
9-13
14-16
17-20
COMBINATION THERAPY FOR DIABETIC POLYNEUROPATHY
Abstract
The paper considers current views on the pathogenesis of diabetic polyneuropathy (DPN) and the role of complex metabolic agents in the treatment of this complication of diabetes mellitus. It gives the results of a clinical trial of the efficacy and safety of Cocarnit, which allow one to consider that it may be successfully used in the combination treatment of DPN.
Vrach. 2015;26(1):21-24
21-24
THE NOVEL DUAL DELAYED-RELEASE PROTON PUMP INHIBITOR DEXLANSOPRAZOLE (DEXILANT®)
Abstract
The paper provides a current review of the specific features of the pharmacokinetics of the novel innovative dual delayed-release proton pump inhibitor (PPI) dexlansoprazole (Dexilant®). Due to its two-step release and increased blood residence time, the drug has shown the high efficacy in treating different forms of gastroesophageal reflux disease, which is greater to that of other PPIs in terms of a number of indicators, and ensures higher patient adherence to treatment.
Vrach. 2015;26(1):25-29
25-29
NUROFEN IN RECTAL SUPPOSITORIES IN FEBRILE CHILREN
Abstract
The paper gives the main features and advantages of ibuprofen (Nurofen) as rectal suppositories over acetaminophen (Paracetamol) in young children with acute respiratory viral infections accompanied by hyperthermia; Nurofen suppositories provide a more pronounced and prolonged antipyretic effect, abolish fever 1.2 times more promptly, and have a higher safety profile.
Vrach. 2015;26(1):29-32
29-32
32-35
36-39
CLINICAL AND IMMUNOLOGICAL RATIONALE FOR THE USE IN THERAPY IMMUNOMODULATOR GALAVIT® MIX-INFECTIONS OF THE GENITAL TRACT
Abstract
The article discusses the effects of the drug immunotropic Galavit® (Selba, Russia) in the treatment of viral and bacterial infections of the urogenital tract. Purpose - to assess the impact of the drug on Galavit® indicators of innate and adaptive immunity in the complex therapy of inflammatory diseases of the urogenital tract of women of reproductive age, the etiological agent of which are: herpes simplex virus type 2 and U. urealyticum и M. hominis. The results of the study showed that the introduction of the drug to patients in a comprehensive scheme Galavit® therapy at an initial dose 100 mg daily (5 injections); followed by 100 mg every other day (5 injections); At the end of the course-10 rectal suppository 1 time in 3 days promotes normalization factors antimicrobial protection and resolution of clinical symptoms.
Vrach. 2015;26(1):40-43
40-43
PRIMARY BILIARY CIRRHOSIS: DIAGNOSTIC CRITERIA AND THE AUTHORS’ EXPERIENCE WITH THERAPY
Abstract
The incidence rate of primary biliary cirrhosis (PBC) is 4 to 40 per 100,000 in people of different ethnicities. The basic morphological substrate of the disease is autoimmune nonpurulent destructive cholangitis characterized by the development of clinical and laboratory intrahepatic cholestasis. The treatment of PBC involves mandatory long use of ursodeoxycholic acid (UDCA) in a dose of 13-15 mg/kg/day. The authors’ experience with UDCA in the retrospective investigation demonstrates it necessary to study the clinical efficacy of its preparations in randomized controlled prospective trials.
Vrach. 2015;26(1):44-46
44-46
PHONATION IN PEDIATRIC PRACTICE
Abstract
Tissue disorders that are the basis for most diseases cannot be considered in isolation of transport function. The latteTs failure may be caused by deficiency of the energy resources ensuring metabolism. Incorporation of phonation into the therapy program permits transport function to be improved.
Vrach. 2015;26(1):47-50
47-50
51-54
COMBINATION THERAPY FOR ACUTE SALPINGOOPHORITIS
Abstract
The paper describes the experience with Tiotriazoline in the combination therapy of acute salpingoophoritis. There is convincing evidence that the drug has a positive effect on the clinical course of the disease, the indicators of the acute phase of an inflammatory process, and the functional status of the liver.
Vrach. 2015;26(1):54-57
54-57
58-59
60-63
64-68
68-73
73-75
STRATEGIES FOR REPLACEMENT THERAPY FOR EXOCRINE PANCREATIC INSUFFICIENCY: A PHARMACOECONOMIC ANALYSIS
Abstract
A comparative pharmacoeconomic assessment of different strategies for pharmacotherapy was made in patients with chronic pancreatitis and exocrine pancreatic insufficiency in an inpatient setting. It demonstrated the clinical and economic benefits of Ermital.
Vrach. 2015;26(1):75-79
75-79
EARLY DIAGNOSIS OF ACUTE KIDNEY INJURY IN PRETERM INFANTS AND POSSIBILITIES OF ITS CORRECTION WITH ENERGY-RICH DRUGS
Abstract
The paper gives data on the possibility of using the early markers (serum lipocalin 2 and cystatin C) of acute kidney injury (AKI) in preterm infants and shows the specific features of carnitine metabolism in preterm babies at different gestational ages with AKI, the basis for which is hypoxic renal tissue damage. It presents the preliminary results of using L-carnitine in the infants with AKI.
Vrach. 2015;26(1):79-83
79-83
83-86
AGAINST GIRLS STAVROPOL OFFICIAL MEDICINE AND DISEASE PREVENTION
Abstract
The results of the study of lifestyle of girls 18-22 years old. Marked by a low level of confidence of the respondents to the official medicine. Revealed their attitudes towards a healthy lifestyle and get information about it. Documented gaps in preventive activities of doctors.
Vrach. 2015;26(1):87-88
87-88